Celldex Therapeutics | CLDX

Aktienkurs
41.95
Täglich Wechseln
-0.66 -1.55%
Monatlich
9.50%
Jährlich
64.51%
Q3 Prognose
41.05

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-11-11 FY2026Q3 PM -1.07 -1.01
2026-08-06 FY2026Q2 PM -0.94 -1.06 -0.85
2026-05-07 FY2026Q1 PM -1.18 -1.19 -0.71
2026-02-25 FY2025Q4 PM -1.22 -1 -0.71
2025-11-10 FY2025Q3 PM -1.01 -0.9 -0.64



Preis Chg Tag Jahr Datum
AbbVie 249.46 -1.36 -0.54% 20.69% 2026-08-14
Agenus 7.32 0.32 4.57% 58.10% 2026-08-14
Amgen 415.21 -2.63 -0.63% 40.05% 2026-08-14
Bristol-Myers Squibb 63.83 -0.82 -1.27% 31.77% 2026-08-14
Celldex Therapeutics 41.95 -0.66 -1.55% 64.51% 2026-08-14
Glaxosmithkline 50.30 -0.60 -1.18% 33.85% 2026-08-12
Nektar Therapeutics 73.02 -2.90 -3.82% 167.87% 2026-08-14
Northwest Biotherapeutics 0.19 0.001 0.64% -20.04% 2026-08-13
Pfizer 26.79 -0.01 -0.04% 6.56% 2026-08-14
Rigel Pharmaceuticals 42.58 1.79 4.39% 7.77% 2026-08-14

Preis Tag Jahr Datum
USND 26729 -73.86 -0.28% 23.61% 2026-08-14
US2000 3068 15.57 0.51% 34.20% 2026-08-14